Cystatin C in Alzheimer's disease

Frontiers in Molecular Neuroscience

Volumn , Issue JUNE 2012, 2012, Pages

  Kaur, Gurjinder ^a   Levy, Efrat ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

A ; Alzheimer's disease; Amyloid; Cerebral amyloidosis; Cystatin C; Neurodegeneration

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CYSTATIN C; CYSTEINE PROTEINASE; GLIAL FIBRILLARY ACIDIC PROTEIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; AUTOPHAGY; BRAIN BLOOD VESSEL; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROSPINAL FLUID; DNA POLYMORPHISM; DOWN SYNDROME; ENZYME INHIBITION; FAMILIAL DISEASE; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; IMMUNOREACTIVITY; MULTIINFARCT DEMENTIA; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROFIBRILLARY TANGLE; NEUROFILAMENT; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OLIGOMERIZATION; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; REVIEW;

EID: 84864015486     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2012.00079     Document Type: Review

References (150)

1. G. M. Hochwald, A. J. Pepe and G. J. Thorbecke: Trace proteins in biological fluids. IV. Physicochemical properties and sites of formation of y trace and ß trace proteins. Proc Soc Exp Med, 124, 961-966 (1967)
2. L. A. Bobek and M. J. Levine: Cystatins-inhibitors of cysteine proteinases. Critical Reviews in Oral Biology & Medicine, 3, 307-332 (1992)
3. V. Turk, V. Stoka and D. Turk: Cystatins: biochemical and structural properties, and medical relevance. Front Biosci, 13, 5406-5420 (2008)
4. K. Hakansson, C. Huh, A. Grubb, S. Karlsson and M. Abrahamson: Mouse and rat cystatin C: Escherichia coli production, characterization and tissue distribution. Comp Biochem Physiol B Biochem Mol Biol, 114(3), 303-311 (1996)
5. T. Miyake, Y. Gahara, M. Nakayama, H. Yamada, K. Uwabe and T. Kitamura: Up-regulation of cystatin C by microglia in the rat facial nucleus following axotomy. Brain Res Mol Brain Res, 37(1-2), 273-282 (1996)
6. D. E. Palm, N. W. Knuckey, M. J. Primiano, A. G. Spangenberger and C. E. Johanson: Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia. Brain Research, 691, 1-8 (1995)
7. O. Yasuhara, K. Hanai, I. Ohkubo, M. Sasaki, P. L. McGeer and H. Kimura: Expression of cystatin C in rat, monkey and human brains. Brain Research, 628, 85-92 (1993)
8. U. H. Lerner and A. Grubb: Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy. Journal of Bone & Mineral Research, 7, 433-440 (1992)
9. C. G. Huh, K. Hakansson, C. M. Nathanson, U. P. Thorgeirsson, N. Jonsson, A. Grubb, M. Abrahamson and S. Karlsson: Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene. Mol Pathol, 52(6), 332-340 (1999)
10. P. Taupin, J. Ray, W. H. Fischer, S. T. Suhr, K. Hakansson, A. Grubb and F. H. Gage: FGF-2-Responsive neural stem cell proliferation requires CCg, a novel Autocrine/Paracrine cofactor. Neuron, 28(2), 385-397. (2000)
11. A. H. Warfel, D. Zucker-Franklin, B. Frangione and J. Ghiso: Constitutive secretion of cystatin C (y-trace) by monocytes and macrophages and its downregulation after stimulation. Journal of Experimental Medicine, 166, 1912-1917 (1987)
12. Q. Sun: Growth stimulation of 3T3 fibroblasts by cystatin. Experimental Cell Research, 180, 150-160 (1989)
13. C. Tavera, J. Leung-Tack, D. Prevot, M. C. Gensac, J. Martinez, P. Fulcrand and A. Colle: Cystatin C secretion by rat glomerular mesangial cells: autocrine loop for in vitro growth-promoting activity. Biochemical & Biophysical Research Communications, 182, 1082-1088 (1992)
14. T. Kumada, A. Hasegawa, Y. Iwasaki, H. Baba and K. Ikenaka: Isolation of cystatin C via functional cloning of astrocyte differentiation factors. Dev Neurosci, 26(1), 68-76 (2004)
15. G. Filler, A. Bokenkamp, W. Hofmann, T. Le Bricon, C. Martinez-Bru and A. Grubb: Cystatin C as a marker of GFR--history, indications, and future research. Clin Biochem, 38(1), 1-8 (2005)
16. S. Gauthier, G. Kaur, W. Mi, B. Tizon and E. Levy: Protective mechanisms by cystatin C in neurodegenerative diseases. FrontBiosci (ScholEd), 3, 541-554 (2011)
17. B. Turk, D. Turk and V. Turk: Lysosomal cysteine proteases: more than scavengers. Biochim Biophys Acta, 1477(1-2), 98-111 (2000)
18. Y. Nakamura, M. Takeda, H. Suzuki, H. Hattori, K. Tada, S. Hariguchi, S. Hashimoto and T. Nishimura: Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease. Neuroscience Letters, 130, 195-198 (1991)
19. B. Tizon and E. Levy: Protease inhibitors and their involvement in neurological disorders. In: Handbook of Neurochemistry and Molecular Neurobiology. Ed A. Lajtha. Springer Publishers, New York (2006)
20. G. F. Tu, A. R. Aldred, B. R. Southwell and G. Schreiber: Strong conservation of the expression of cystatin C gene in choroid plexus. American Journal of Physiology, 263, R195-R200 (1992)
21. A. O. Grubb: Diagnostic value of analysis of cystatin C and protein HC in biological fluids. Clinical Nephrology, 38 Suppl 1, S20-S27 (1992)
22. W. Maetzler, B. Schmid, M. Synofzik, C. Schulte, K. Riester, H. Huber, K. Brockmann, T. Gasser, D. Berg and A. Melms: The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in Lewy body disease. J Alzheimers Dis, 19(3), 937-942 (2010)
23. Y. Yang, S. Liu, Z. Qin, Y. Cui, Y. Qin and S. Bai: Alteration of cystatin C levels in cerebrospinal fluid of patients with Guillain-Barre Syndrome by a proteomical approach. Mol Biol Rep, 36(4), 677-682 (2009)
24. J. Mares, P. Kanovsky, R. Herzig, D. Stejskal, J. Vavrouskova, P. Hlustik, H. Vranova, S. Burval, J. Zapletalova, V. Pidrman, R. Obereigneru, A. Suchy, J. Vesely, J. Podivinsky and K. Urbanek: New laboratory markers in diagnosis of alzheimer dementia. Neurol Res, 31(10), 1056-1059 (2009)
25. F. Mori, K. Tanji, Y. Miki and K. Wakabayashi: Decreased cystatin C immunoreactivity in spinal motor neurons and astrocytes in amyotrophic lateral sclerosis. Journal of Neuropathological Experimental Neurology, 68(11), 1200-1206 (2009)
26. S. Tsuji-Akimoto, I. Yabe, M. Niino, S. Kikuchi and H. Sasaki: Cystatin C in cerebrospinal fluid as a biomarker of ALS. Neuroscience Letters, 452(1), 52-55 (2009)
27. G. M. Pasinetti, L. H. Ungar, D. J. Lange, S. Yemul, H. Deng, X. Yuan, R. H. Brown, M. E. Cudkowicz, K. Newhall, E. Peskind, S. Marcus and L. Ho: Identification of potential CSF biomarkers in ALS. Neurology, 66(8), 1218-1222 (2006)
28. M. E. Wilson, I. Boumaza, D. Lacomis and R. Bowser: Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis. PLoS ONE, 5(12), e15133 (2010)
29. K. Okamoto, Y. Mizuno and Y. Fujita: Bunina bodies in amyotrophic lateral sclerosis. Neuropathology, 28(2), 109-115 (2008)
30. A. H. Simonsen, J. McGuire, V. N. Podust, N. O. Hagnelius, T. K. Nilsson, E. Kapaki, D. Vassilopoulos and G. Waldemar: A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia. Dement Geriatr Cogn Disord, 24(6), 434-440 (2007)
31. S. F. Hansson, U. Andreasson, M. Wall, I. Skoog, N. Andreasen, A. Wallin, H. Zetterberg and K. Blennow: Reduced levels of amyloid-ß-binding proteins in cerebrospinal fluid from Alzheimer's disease patients. J Alzheimers Dis, 16(2), 389-397 (2009)
32. A. Deng, M. C. Irizarry, R. M. Nitsch, J. H. Growdon and G. W. Rebeck: Elevation of cystatin C in susceptible neurons in alzheimer's disease. Am J Pathol, 159(3), 1061-1068. (2001)
33. E. Levy, M. Sastre, A. Kumar, G. Gallo, P. Piccardo, B. Ghetti and F. Tagliavini: Codeposition of cystatin C with amyloid-ß protein in the brain of Alzheimer's disease patients. J Neuropathol Exp Neurol, 60, 94-104 (2001)
34. H. T. Yang, S. Wilkening and M. J. Iadarola: Spinal cord genes enriched in rat dorsal horn and induced by noxious stimulation identified by subtraction cloning and differential hybridization. Neuroscience, 103(2), 493-502 (2001)
35. G. X. Ying, C. Huang, Z. H. Jiang, X. Liu, N. H. Jing and C. F. Zhou: Up-regulation of cystatin C expression in the murine hippocampus following perforant path transections. Neuroscience, 112(2), 289-298 (2002)
36. K. Katakai, M. Shinoda, K. Kabeya, M. Watanabe, Y. Ohe, M. Mori and K. Ishikawa: Changes in distribution of cystatin C, apolipoprotein E and ferritin in rat hypothalamus after hypophysectomy. J Neuroendocrinol, 9(4), 247-253 (1997)
37. H. Ishimaru, K. Ishikawa, Y. Ohe, A. Takahashi and Y. Maruyama: Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus. Brain Res, 709(2), 155-162 (1996)
38. T. J. Pirttila and A. Pitkanen: Cystatin C expression is increased in the hippocampus following photothrombotic stroke in rat. Neurosci Lett, 395(2), 108-113 (2006)
39. K. Lukasiuk, T. J. Pirttila and A. Pitkanen: Upregulation of cystatin C expression in the rat hippocampus during epileptogenesis in the amygdala stimulation model of temporal lobe epilepsy. Epilepsia, 43 Suppl 5, 137-145 (2002)
40. H. Hendriksen, N. A. Datson, W. E. Ghijsen, E. A. van Vliet, F. H. da Silva, J. A. Gorter and E. Vreugdenhil: Altered hippocampal gene expression prior to the onset of spontaneous seizures in the rat post-status epilepticus model. Eur J Neurosci, 14(9), 1475-1484 (2001)
41. E. Aronica, E. A. van Vliet, E. Hendriksen, D. Troost, F. H. Lopes da Silva and J. A. Gorter: Cystatin C, a cysteine protease inhibitor, is persistently up-regulated in neurons and glia in a rat model for mesial temporal lobe epilepsy. Eur J Neurosci, 14(9), 1485-1491 (2001)
42. D. A. Butterfield and D. Boyd-Kimball: Amyloid ß-peptide(1-42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathol, 14(4), 426-432 (2004)
43. W. L. Klein, G. A. Krafft and C. E. Finch: Targeting small Aß oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci, 24(4), 219-224 (2001)
44. D. M. Walsh and D. J. Selkoe: Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron, 44(1), 181-193 (2004)
45. H. V. Vinters, G. S. Nishimura, D. L. Secor and W. M. Pardridge: Immunoreactive A4 and y-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease. American Journal of Pathology, 137, 233-240 (1990)
46. K. Maruyama, S. Ikeda, T. Ishihara, D. Allsop and N. Yanagisawa: Immunohistochemical characterization of cerebrovascular amyloid in 46 autopsied cases using antibodies to ß protein and cystatin C. Stroke, 21, 397-403 (1990)
47. Y. Itoh, M. Yamada, M. Hayakawa, E. Otomo and T. Miyatake: Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. Journal of the Neurological Sciences, 116, 135-141 (1993)
48. J. Haan, M. L. C. Maat-Schieman, S. G. van Duinen, O. Jensson, L. Thorsteinsson and R. A. C. Roos: Co-localization of ß/A4 and cystatin C in cortical blood vessels in Dutch, but not in Icelandic hereditary cerebral hemorrhage with amyloidosis. Acta Neurologica Scandinavica, 89, 367-371 (1994)
49. K. Ii, H. Ito, E. Kominami and A. Hirano: Abnormal distribution of cathepsin proteinases and endogenous inhibitors (cystatins) in the hippocampus of patients with Alzheimer's disease, parkinsonism-dementia complex on Guam, and senile dementia and in the aged. Virchows Archiv-A, Pathological Anatomy & Histopathology, 423(3), 185-194 (1993)
50. H. G. Bernstein, R. Rinne, H. Kirschke, M. Jarvinen, B. Knofel and A. Rinne: Cystatin A-like immunoreactivity is widely distributed in human brain and accumulates in neuritic plaques of Alzheimer disease subjects. Brain Res Bull, 33, 477-481 (1994)
51. A. Nagai, M. Terashima, A. M. Sheikh, Y. Notsu, K. Shimode, S. Yamaguchi, S. Kobayashi, S. U. Kim and J. Masuda: Involvement of cystatin C in pathophysiology of CNS diseases. Front Biosci, 13, 3470-3479 (2008)
52. A. Arnason: Apoplexie und ihre Vererbung. Acta Psychiatr Neurol Scand (Suppl), VII, 1-180 (1935)
53. G. Gudmundsson, J. Hallgrimsson, T. A. Jonasson and O. Bjarnason: Hereditary cerebral haemorrhage with amyloidosis. Brain, 95, 387-404 (1972)
54. I. Olafsson, L. Thorsteinsson and O. Jensson: The molecular pathology of hereditary cystatin C amyloid angiopathy causing brain hemorrhage. Brain Pathology, 6, 121-126 (1996)
55. D. H. Cohen, H. Feiner, O. Jensson and B. Frangione: Amyloid fibril in hereditary cerebral hemorrhage with amyloidosis (HCHWA) is related to the gastroentero-pancreatic neuroendocrine protein, y trace. Journal of Experimental Medicine, 158, 623-628 (1983)
56. J. Ghiso, B. Pons-Estel and B. Frangione: Hereditary cerebral amyloid angiopathy: the amyloid fibrils contain a protein which is a variant of cystatin C, an inhibitor of lysosomal cysteine proteases. Biochemical & Biophysical Research Communications, 136, 548-554 (1986)
57. A. Palsdottir, M. Abrahamson, L. Thorsteinsson, A. Arnason, I. Olafsson, A. O. Grubb and O. Jensson: Mutation in cystatin C gene causes hereditary brain haemorrhage. Lancet, 2, 603-604 (1988)
58. E. Levy, C. Lopez-Otin, J. Ghiso, D. Geltner and B. Frangione: Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases. Journal of Experimental Medicine, 169, 1771-1778 (1989)
59. M. Abrahamson, I. Olafsson, A. Palsdottir, M. Ulvsback, A. Lundwall, O. Jensson and A. O. Grubb: Structure and expression of the human cystatin C gene. Biochemical Journal, 268, 287-294 (1990)
60. C. Graffagnino, M. H. Herbstreith, D. E. Schmechel, E. Levy, A. D. Roses and M. J. Alberts: Cystatin C mutation in an elderly man with sporadic amyloid angiopathy and intracerebral hemorrhage. Stroke, 26, 2190-2193 (1995)
61. M. O. McCarron, J. A. Nicoll, J. Stewart, J. W. Ironside, D. M. Mann, S. Love, D. I. Graham and A. Grubb: Absence of cystatin C mutation in sporadic cerebral amyloid angiopathy-related hemorrhage. Neurology, 54(1), 242-244 (2000)
62. H. V. Vinters: Cerebral amyloid angiopathy: a microvascular link between parenchymal and vascular dementia? Ann Neurol, 49(6), 691-693 (2001)
63. A. Nagai, S. Kobayashi, K. Shimode, K. Imaoka, N. Umegae, S. Fujihara and M. Nakamura: No mutations in cystatin C gene in cerebral amyloid angiopathy with cystatin C deposition. Mol Chem Neuropathol, 33, 63-78 (1998)
64. K. Maruyama, F. Kametani, S. Ikeda, T. Ishihara and N. Yanagisawa: Characterization of amyloid fibril protein from a case of CAA showing immunohistochemical reactivity for both ß protein and cystatin C. Neuroscience Letters, 144, 38-42 (1992)
65. L. Wei, L. C. Walker and E. Levy: Cystatin C: Icelandic-like mutation in an animal model of cerebrovascular ß amyloidosis. Stroke, 27, 2080-2085 (1996)
66. H. M. Wisniewski and R. D. Terry: Morphology of the aging brain, human and animal. Progress in Brain Research, 40, 167-186 (1973)
67. L. C. Walker, C. Masters, K. Beyreuther and D. L. Price: Amyloid in the brains of aged squirrel monkeys. Acta Neuropathol, 80, 381-387 (1990)
68. D. L. Price, L. J. Martin, S. S. Sisodia, L. C. Walker, M. L. Voytko, M. V. Wagster, L. C. Cork and V. E. Koliatsos: The aged nonhuman primate. A model for the behavioral and brain abnormalities occurring in aged humans. In: Alzheimer's disease. Ed R. D. Terry, R. Katzman&K. L. Blick. Raven Press, New York (1994)
69. P. Lindahl, D. Ripoll, M. Abrahamson, J. S. Mort and A. C. Storer: Evidence for the interaction of valine-10 in cystatin C with the S2 subsite of cathepsin B. Biochemistry, 33, 43844392 (1994)
70. M. Pawlik, M. Sastre, M. Calero, P. M. Mathews, S. D. Schmidt, R. A. Nixon and E. Levy: Overexpression of human cystatin C in transgenic mice does not affect levels of endogenous brain amyloid ß peptide. J Mol Neurosci, 22(1-2), 13-18 (2004)
71. M. Pawlik, V. Danilov, K. Mancevska, M. Morbin, F. Tagliavini and E. Levy: Hemorrhages caused by overexpression of cystatin C in transgenic mice. In: Alzheimer's Association and Related disorders. Neurobiol Aging, (2002)
72. T. Steinhoff, E. Moritz, M. A. Wollmer, M. H. Mohajeri, S. Kins and R. M. Nitsch: Increased cystatin C in astrocytes of transgenic mice expressing the K670N-M671L mutation of the amyloid precursor protein and deposition in brain amyloid plaques. Neurobiol Dis, 8(4), 647-654. (2001)
73. D. T. Winkler, L. Bondolfi, M. C. Herzig, L. Jann, M. E. Calhoun, K. H. Wiederhold, M. Tolnay, M. Staufenbiel and M. Jucker: Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci, 21(5), 1619-1627. (2001)
74. S. Kiuru, O. Salonen and M. Haltia: Gelsolin-related spinal and cerebral amyloid angiopathy. Annals of Neurology, 45, 305-311 (1999)
75. S. Kiuru-Enari, H. Somer, A. M. Seppalainen, I. L. Notkola and M. Haltia: Neuromuscular pathology in hereditary gelsolin amyloidosis. J Neuropathol Exp Neurol, 61(6), 565-571. (2002)
76. J. Ghiso, G. T. Plant, T. Revesz, T. Wisniewski and B. Frangione: Familial cerebral amyloid angiopathy (British type) with nonneuritic amyloid plaque formation may be due to a novel amyloid protein. Journal of the Neurological Sciences, 129, 74-75 (1995)
77. J. Sundelof, J. Arnlov, E. Ingelsson, J. Sundstrom, S. Basu, B. Zethelius, A. Larsson, M. C. Irizarry, V. Giedraitis, E. Ronnemaa, M. Degerman-Gunnarsson, B. T. Hyman, H. Basun, L. Kilander and L. Lannfelt: Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology, 71(14), 1072-1079 (2008)
78. J. Sundelof, J. Sundstrom, O. Hansson, M. Eriksdotter-Jonhagen, V. Giedraitis, A. Larsson, M. Degerman-Gunnarsson, M. Ingelsson, L. Minthon, K. Blennow, L. Kilander, H. Basun and L. Lannfelt: Cystatin C levels are positively correlated with both Aß42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls. J Alzheimers Dis, 21(2), 471-478 (2010)
79. R. Craig-Schapiro, M. Kuhn, C. Xiong, E. H. Pickering, J. Liu, T. P. Misko, R. J. Perrin, K. R. Bales, H. Soares, A. M. Fagan and D. M. Holtzman: Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer's disease diagnosis and prognosis. PLoS ONE, 6(4), e18850 (2011)
80. R. J. Perrin, R. Craig-Schapiro, J. P. Malone, A. R. Shah, P. Gilmore, A. E. Davis, C. M. Roe, E. R. Peskind, G. Li, D. R. Galasko, C. M. Clark, J. F. Quinn, J. A. Kaye, J. C. Morris, D. M. Holtzman, R. R. Townsend and A. M. Fagan: Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS ONE, 6(1), e16032 (2011)
81. A. M. Ndjole, C. Bodolea, T. Nilsen, T. Gordh, M. Flodin and A. Larsson: Determination of cerebrospinal fluid cystatin C on Architect ci8200. J Immunol Methods, 360(1-2), 84-88 (2010)
82. M. Zellner, M. Veitinger and E. Umlauf: The role of proteomics in dementia and Alzheimer's disease. Acta Neuropathol, 118(1), 181-195 (2009)
83. R. Ghidoni, L. Benussi, M. Glionna, S. Desenzani, V. Albertini, E. Levy, E. Emanuele and G. Binetti: Plasma cystatin C and risk of developing Alzheimer's disease in subjects with mild cognitive impairment. J Alzheimers Dis, 22(3), 985-991 (2010)
84. M. Abrahamson, M. Q. Islam, J. Szpirer, C. Szpirer and G. Levan: The human cystatin C gene (CST3), mutated in hereditary cystatin C amyloid angiopathy, is located on chromosome 20. Human Genetics, 82, 223-226 (1989)
85. E. Saitoh, L. M. Sabatini, R. L. Eddy, T. B. Shows, E. A. Azen, S. Isemura and K. Sanada: The human cystatin C gene (CST3) is a member of the cystatin gene family which is localized on chromosome 20. Biochemical & Biophysical Research Communications, 162, 1324-1331 (1989)
86. M. Balbin and M. Abrahamson: SstII polymorphic sites in the promoter region of the human cystatin C gene. Human Genetics, 87, 751-752 (1991)
87. M. Balbin, A. O. Grubb and M. Abrahamson: An Ala/Thr variation in the coding region of the human cystatin C gene (CST3) detected as a SstII polymorphism. Human Genetics, 92, 206-207 (1993)
88. F. C. Crawford, M. J. Freeman, J. A. Schinka, L. I. Abdullah, M. Gold, R. Hartman, K. Krivian, M. D. Morris, D. Richards, R. Duara, R. Anand and M. J. Mullan: A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease. Neurology, 55(6), 763-768 (2000)
89. U. Finckh, H. von Der Kammer, J. Velden, T. Michel, B. Andresen, A. Deng, J. Zhang, T. Muller-Thomsen, K. Zuchowski, G. Menzer, U. Mann, A. Papassotiropoulos, R. Heun, J. Zurdel, F. Holst, L. Benussi, G. Stoppe, J. Reiss, A. R. Miserez, H. B. Staehelin, G. W. Rebeck, B. T. Hyman, G. Binetti, C. Hock, J. H. Growdon and R. M. Nitsch: Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch Neurol, 57(11), 1579-1583 (2000)
90. K. Beyer, J. I. Lao, M. Gomez, N. Riutort, P. Latorre, J. L. Mate and A. Ariza: Alzheimer's disease and the cystatin C gene polymorphism: an association study. Neurosci Lett, 315(1-2), 17-20 (2001)
91. J. M. Olson, K. A. Goddard and D. M. Dudek: A second locus for very-late-onset Alzheimer disease: a genome scan reveals linkage to 20p and epistasis between 20p and the amyloid precursor protein region. Am J Hum Genet, 71(1), 154-161 (2002)
92. K. A. Goddard, J. M. Olson, H. Payami, M. Van Der Voet, H. Kuivaniemi and G. Tromp: Evidence of linkage and association on chromosome 20 for late-onset Alzheimer disease. Neurogenetics, 5(2), 121-128 (2004)
93. H. M. Cathcart, R. Huang, I. S. Lanham, E. H. Corder and S. E. Poduslo: Cystatin C as a risk factor for Alzheimer disease. Neurology, 64(4), 755-757 (2005)
94. C. Lin, S. T. Wang, C. W. Wu, L. J. Chuo and Y. M. Kuo: The association of a cystatin C gene polymorphism with late-onset Alzheimer's disease and vascular dementia. Chin J Physiol, 46(3), 111-115 (2003)
95. L. Bertram, M. B. McQueen, K. Mullin, D. Blacker and R. E. Tanzi: Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet, 39(1), 17-23 (2007)
96. R. C. Dodel, Y. Du, C. Depboylu, A. Kurz, B. Eastwood, M. Farlow, W. H. Oertel, U. Muller and M. Riemenschneider: A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD. Neurology, 58(4), 664 (2002)
97. G. Roks, M. Cruts, A. J. Slooter, B. Dermaut, A. Hofman, C. Van Broeckhoven and C. M. Van Duijn: The cystatin C polymorphism is not associated with early onset Alzheimer's disease. Neurology, 57(2), 366-367. (2001)
98. H. Maruyama, Y. Izumi, M. Oda, T. Torii, H. Morino, H. Toji, K. Sasaki, H. Terasawa, S. Nakamura and H. Kawakami: Lack of an association between cystatin C gene polymorphisms in Japanese patients with Alzheimer's disease. Neurology, 57(2), 337-339. (2001)
99. S. Helisalmi, A. Vakeva, M. Hiltunen and H. Soininen: Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease. Dement Geriatr Cogn Disord, 27(4), 318321 (2009)
100. M. Parfitt, R. Crook, P. Roques, M. Rossor and M. C. Chartier-Harlin: The cystatin-C gene is not linked to early onset familial Alzheimer's disease. Neuroscience Letters, 154, 81-83 (1993)
101. Y. Hua, H. Zhao, X. Lu, Y. Kong and H. Jin: Meta-analysis of the cystatin C(CST3) Gene G73A polymorphism and susceptibility to Alzheimer's disease. Int J Neurosci (2012)
102. B. Wang, Y. C. Xie, Z. Yang, D. Peng, J. Wang, S. Zhou, S. Li and X. Ma: Lack of an association between Alzheimer's disease and the cystatin C (CST3) gene G73A polymorphism in Mainland Chinese. Dement Geriatr Cogn Disord, 25(5), 461-464 (2008)
103. Gene overview of all published AD-association studies for CST3: http://www.alzforum.org/res/com/gen/alzgene/geneoverview.asp?geneid=66. In, 104. L. Benussi, R. Ghidoni, T. Steinhoff, A. Alberici, A. Villa, F. Mazzoli, F. Nicosia, L. Barbiero, L. Broglio, E. Feudatari, S. Signorini, U. Finckh, R. M. Nitsch and G. Binetti: Alzheimer disease-associated cystatin C variant undergoes impaired secretion. Neurobiol Dis, 13(1), 15-21 (2003)
104. D. Noto, A. B. Cefalu, C. M. Barbagallo, A. Pace, M. Rizzo, G. Marino, R. Caldarella, A. Castello, V. Pernice, A. Notarbartolo and M. R. Averna: Cystatin C levels are decreased in acute myocardial infarction: effect of cystatin C G73A gene polymorphism on plasma levels. Int J Cardiol, 101(2), 213-217 (2005)
105. Y. Yamamoto-Watanabe, M. Watanabe, M. Jackson, H. Akimoto, K. Sugimoto, M. Yasujima, Y. Wakasaya, E. Matsubara, T. Kawarabayashi, Y. Harigaya, A. R. Lyndon and M. Shoji: Quantification of cystatin C in cerebrospinal fluid from various neurological disorders and correlation with G73A polymorphism in CST3. Brain Research, 1361, 140-145 (2010)
106. L. Paraoan, A. Ratnayaka, D. G. Spiller, P. Hiscott, M. R. White and I. Grierson: Unexpected intracellular localization of the AMD-associated cystatin C variant. Traffic, 5(11), 884-895 (2004)
107. V. Jelic, P. Julin, M. Shigeta, A. Nordberg, L. Lannfelt, B. Winblad and L. O. Wahlund: Apolipoprotein E epsilon4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence. J Neurol Neurosurg Psychiatry, 63(1), 59-65 (1997)
108. M. Lehtovirta, J. Partanen, M. Kononen, H. Soininen, S. Helisalmi, A. Mannermaa, M. Ryynanen, P. Hartikainen and P. Riekkinen,: Spectral analysis of EEG in Alzheimer's disease: relation to apolipoprotein E polymorphism. Neurobiol Aging, 17(4), 523-526 (1996)
109. M. Lehtovirta, J. Partanen, M. Kononen, J. Hiltunen, S. Helisalmi, P. Hartikainen, P. Riekkinen, and H. Soininen: A longitudinal quantitative EEG study of Alzheimer's disease: relation to apolipoprotein E polymorphism. Dement Geriatr Cogn Disord, 11(1), 29-35 (2000)
110. C. Babiloni, L. Benussi, G. Binetti, P. Bosco, G. Busonero, S. Cesaretti, G. Dal Forno, C. Del Percio, R. Ferri, G. Frisoni, G. Roberta, G. Rodriguez, R. Squitti and P. M. Rossini: Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: A multicentric study. Neuroimage, 29, 948-964 (2006)
111. R. Ghidoni, L. Benussi, A. Paterlini, C. Missale, A. Usardi, R. Rossi, L. Barbiero, P. Spano and G. Binetti: Presenilin 2 mutations alter cystatin C trafficking in mouse primary neurons. Neurobiol Aging, 28(3), 371-376 (2007)
112. L. Wei, Y. Berman, E. M. Castano, M. Cadene, R. C. Beavis, L. Devi and E. Levy: Instability of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type. Journal of Biological Chemistry, 273, 11806-11814 (1998)
113. L. Paraoan, M. R. White, D. G. Spiller, I. Grierson and B. E. Maden: Precursor cystatin C in cultured retinal pigment epithelium cells: evidence for processing through the secretory pathway. Mol Membr Biol, 18(3), 229-236 (2001)
114. R. Ghidoni, A. Paterlini, V. Albertini, M. Glionna, E. Monti, L. Schiaffonati, L. Benussi, E. Levy and G. Binetti: Cystatin C is released in association with exosomes: a new tool of neuronal communication which is unbalanced in Alzheimer's disease. Neurobiology of Aging, 32(8), 14351442 (2011)
115. G. Kaur, P. Mohan, M. Pawlik, S. Derosa, J. Fajiculay, S. Che, A. Grubbs, S. Ginsberg, R. Nixon and E. Levy: Cystatin C rescues degenerating neurons in a cystatin B-knockout mouse model of progressive myoclonus epilepsy. Am J Pathol, 177(5), 2256-2267 (2010)
116. H. G. Bernstein, H. Kirschke, B. Wiederanders, K. H. Pollak, A. Zipress and A. Rinne: The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review. Mol Chem Neuropathol, 27, 225-247 (1996)
117. M. Abrahamson, D. J. Buttle, R. W. Mason, H. Hansson, A. O. Grubb, H. Lilja and K. Ohlsson: Regulation of cystatin C activity by serine proteinases. Biomedica Biochimica Acta, 50, 587-593 (1991)
118. B. Lenarcic, M. Krasovec, A. Ritonja, I. Olafsson and V. Turk: Inactivation of human cystatin C and kininogen by human cathepsin D. FEBSLetters, 280, 211-215 (1991)
119. A. M. Cataldo, J. L. Barnett, S. A. Berman, J. Li, S. Quarless, S. Bursztajn, C. Lippa and R. A. Nixon: Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron, 14, 671-680 (1995)
120. A. M. Cataldo and R. A. Nixon: Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci U S A, 87, 3861-3865 (1990)
121. I. E. Hill, E. Preston, R. Monette and J. P. MacManus: A comparison of cathepsin B processing and distribution during neuronal death in rats following global ischemia or decapitation necrosis. Brain Res, 751(2), 206-216 (1997)
122. T. Nitatori, N. Sato, S. Waguri, Y. Karasawa, H. Araki, K. Shibanai, E. Kominami and Y. Uchiyama: Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci, 15(2), 1001-1011 (1995)
123. T. Yamashima, Y. Kohda, K. Tsuchiya, T. Ueno, J. Yamashita, T. Yoshioka and E. Kominami: Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. Eur J Neurosci, 10(5), 1723-1733 (1998)
124. K. Tsuchiya, Y. Kohda, M. Yoshida, L. Zhao, T. Ueno, J. Yamashita, T. Yoshioka, E. Kominami and T. Yamashima: Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors. Exp Neurol, 155(2), 187-194 (1999)
125. B. Sun, Y. Zhou, B. Halabisky, I. Lo, S. H. Cho, S. Mueller-Steiner, N. Devidze, X. Wang, A. Grubb and L. Gan: Cystatin C-cathepsin B axis regulates amyloid ß levels and associated neuronal deficits in an animal model of Alzheimer's disease. Neuron, 60(2), 247-257 (2008)
126. L. A. Pennacchio, D. M. Bouley, K. M. Higgins, M. P. Scott, J. L. Noebels and R. M. Myers: Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat Genet, 20(3), 251-258 (1998)
127. B. Tizon, S. Sahoo, H. Yu, S. Gauthier, A. R. Kumar, P. Mohan, M. Figliola, M. Pawlik, A. Grubb, Y. Uchiyama, S. Bandyopadhyay, A. M. Cuervo, R. A. Nixon and E. Levy: Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines. PLoS One, 5(3), e9819 (2010)
128. M. Sastre, M. Calero, M. Pawlik, P. M. Mathews, A. Kumar, V. Danilov, S. D. Schmidt, R. A. Nixon, B. Frangione and E. Levy: Binding of cystatin C to Alzheimer's amyloid b inhibits amyloid fibril formation. Neurobiol Aging, 25, 1033-1043 (2004)
129. Y. Bai, K. Markham, F. Chen, R. Weerasekera, J. Watts, P. Horne, Y. Wakutani, R. Bagshaw, P. M. Mathews, P. E. Fraser, D. Westaway, P. St George-Hyslop and G. Schmitt-Ulms: The in vivo brain interactome of the amyloid precursor protein. Mol CellProteomics, 7(1), 15-34 (2008)
130. M. L. Selenica, X. Wang, L. Ostergaard-Pedersen, A. Westlind-Danielsson and A. Grubb: Cystatin C reduces the in vitro formation of soluble Aß1-42 oligomers and protofibrils. Scand J Clin Lab Invest, 67(2), 179-190 (2007)
131. B. Tizon, E. M. Ribe, W. Mi, C. M. Troy and E. Levy: Cystatin C protects neuronal cells from amyloid ß-induced toxicity. J Alzheimers Dis, 19(3), 665-894 (2010)
132. P. Juszczyk, G. Paraschiv, A. Szymanska, A. S. Kolodziejczyk, S. Rodziewicz-Motowidlo, Z. Grzonka and M. Przybylski: Binding epitopes and interaction structure of the neuroprotective protease inhibitor cystatin C with ß-amyloid revealed by proteolytic excision mass spectrometry and molecular docking simulation. J Med Chem, 52(8), 2420-2428 (2009)
133. W. Mi, M. Pawlik, M. Sastre, S. S. Jung, D. S. Radvinsky, A. M. Klein, J. Sommer, S. D. Schmidt, R. A. Nixon, P. M. Mathews and E. Levy: Cystatin C inhibits amyloid-ß deposition in Alzheimer's disease mouse models. Nat Genet, 39(12), 1440-1442 (2007)
134. S. A. Kaeser, M. C. Herzig, J. Coomaraswamy, E. Kilger, M. L. Selenica, D. T. Winkler, M. Staufenbiel, E. Levy, A. Grubb and M. Jucker: Cystatin C modulates cerebral ß-amyloidosis. Nat Genet, 39(12), 1437-1439 (2007)
135. W. Mi, S. S. Jung, H. Yu, S. D. Schmidt, R. A. Nixon, P. M. Mathews, F. Tagliavini and E. Levy: Complexes of amyloid-ß and cystatin C in the human central nervous system. J Alzheimers Dis, 18(2), 273-280 (2009)
136. E. Zerovnik, R. A. Staniforth and D. Turk: Amyloid fibril formation by human stefins: Structure, mechanism & putative functions. Biochimie, 92(11), 1597-1607 (2010)
137. K. Skerget, A. Taler-Vercic, A. Bavdek, V. Hodnik, S. Ceru, M. Tusek-Znidaric, T. Kumm, D. Pitsi, M. Pompe-Novak, P. Palumaa, S. Soriano, N. Kopitar-Jerala, V. Turk, G. Anderluh and E. Zerovnik: Interaction between oligomers of stefin B and amyloid-ß in vitro and in cells. Journal of Biological Chemistry, 285(5), 3201-3210 (2010)
138. A. L. Schwarzman, L. Gregori, M. P. Vitek, S. Lyubski, W. J. Strittmatter, J. J. Enghilde, R. Bhasin, J. Silverman, K. H. Weisgraber, P. K. Coyle, M. G. Zagorski, J. Talafous, M. Eisenberg, A. M. Saunders, A. D. Roses and D. Goldgaber: Transthyretin sequesters amyloid ß protein and prevents amyloid formation. Proceedings of the National Academy of Sciences of the United States of, 91, 8368-8372 (1994)
139. A. L. Schwarzman, M. Tsiper, H. Wente, A. Wang, M. P. Vitek, V. Vasiliev and D. Goldgaber: Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants. Amyloid, 11(1), 1-9 (2004)
140. S. H. Choi, S. N. Leight, V. M. Lee, T. Li, P. C. Wong, J. A. Johnson, M. J. Saraiva and S. S. Sisodia: Accelerated Aß deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin). Journal of Neuroscience, 27(26), 7006-7010 (2007)
141. J. N. Buxbaum, Z. Ye, N. Reixach, L. Friske, C. Levy, P. Das, T. Golde, E. Masliah, A. R. Roberts and T. Bartfai: Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aß toxicity. Proc Natl Acad Sci U S A, 105(7), 2681-2686 (2008)
142. V. P. Chauhan, I. Ray, A. Chauhan and H. M. Wisniewski: Binding of gelsolin, a secretory protein, to amyloid ß-protein. Biochem Biophys Res Commun, 258(2), 241-246 (1999)
143. Y. M. Kuo, T. A. Kokjohn, W. Kalback, D. Luehrs, D. R. Galasko, N. Chevallier, E. H. Koo, M. R. Emmerling and A. E. Roher: Amyloid-ß peptides interact with plasma proteins and erythrocytes: implications for their quantitation in plasma. Biochemical & Biophysical Research Communications, 268(3), 750-756 (2000)
144. M. M. Wilhelmus, W. C. Boelens, I. Otte-Holler, B. Kamps, R. M. de Waal and M. M. Verbeek: Small heat shock proteins inhibit amyloid-ß protein aggregation and cerebrovascular amyloid-ß protein toxicity. Brain Research, 1089(1), 67-78 (2006)
145. Y. Matsuoka, M. Saito, J. LaFrancois, K. Gaynor, V. Olm, L. Wang, E. Casey, Y. Lu, C. Shiratori, C. Lemere and K. Duff: Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to ß-amyloid. Journal of Neuroscience, 23(1), 29-33 (2003)
146. M. M. Wilhelmus, R. M. de Waal and M. M. Verbeek: Heat shock proteins and amateur chaperones in amyloid-ß accumulation and clearance in Alzheimer's disease. Mol Neurobiol, 35(3), 203-216 (2007)
147. J. M. Parent, T. W. Yu, R. T. Leibowitz, D. H. Geschwind, R. S. Sloviter and D. H. Lowenstein: Dentate granule cell neurogenesis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus. J Neurosci, 17(10), 3727-3738 (1997)
148. J. Nairismagi, O. H. Grohn, M. I. Kettunen, J. Nissinen, R. A. Kauppinen and A. Pitkanen: Progression of brain damage after status epilepticus and its association with epileptogenesis: a quantitative MRI study in a rat model of temporal lobe epilepsy. Epilepsia, 45(9), 1024-1034 (2004)
149. T. J. Pirttila, K. Lukasiuk, K. Hakansson, A. Grubb, M. Abrahamson and A. Pitkanen: Cystatin C modulates neurodegeneration and neurogenesis following status epilepticus in mouse. Neurobiol Dis, 20(2), 241-253 (2005)
150. A. Hasegawa, M. Naruse, S. Hitoshi, Y. Iwasaki, H. Takebayashi and K. Ikenaka: Regulation of glial development by cystatin C. J Neurochem, 100(1), 12-22 (2007)